Information surrounding additional factors in the disease process such as biomarkers involved in dementia (e.g., amyloid and tau protein accumulation in Alzheimer's disease) was not found to be included in the interventions; however, overall, the studies did not specifically state the exact content provided and due to this, the inclusion of this additional information may have occurred. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.